Alternate-day dosing of atorvastatin: effects in treating type 2 diabetic patients with dyslipidaemia
✍ Scribed by J C. Ferrer-García; J. Pérez-Silvestre; I. Martínez-Mir; A. Herrera-Ballester
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 73 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0940-5429
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Elderly insulin-treated diabetic patients have a high risk of severe hypoglycaemia, yet their hypoglycaemic symptom profile has attracted little research. In this study, the frequency and intensity of symptoms of hypoglycaemia were recorded using a validated questionnaire in 132 insulin-treated diab
## Abstract ## Background Severe hypoglycaemia is a potentially life‐threatening condition. The aim of the present study was to compare the frequency of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. ## Methods This prospective, population‐ba
## Background: The plasma cell differentiation antigen (pc-1) is an inhibitor of insulin receptor tyrosine kinase activity, and has been implicated in the pathogenesis of insulin resistance in type 2 diabetes. metformin increases peripheral insulin sensitivity and, therefore, we have studied the ef